<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JDR</journal-id>
<journal-id journal-id-type="hwp">spjdr</journal-id>
<journal-id journal-id-type="nlm-ta">J Dent Res</journal-id>
<journal-title>Journal of Dental Research</journal-title>
<issn pub-type="ppub">0022-0345</issn>
<issn pub-type="epub">1544-0591</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0022034512459655</article-id>
<article-id pub-id-type="publisher-id">10.1177_0022034512459655</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Reports</subject>
<subj-group subj-group-type="heading">
<subject>Biological</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Periostin is Down-regulated during Periodontal Inflammation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Padial-Molina</surname><given-names>M.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512459655">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Volk</surname><given-names>S.L.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512459655">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Taut</surname><given-names>A.D.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512459655">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Giannobile</surname><given-names>W.V.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512459655">1-</xref>
<xref ref-type="aff" rid="aff3-0022034512459655">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Rios</surname><given-names>H.F.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512459655">1</xref>
<xref ref-type="aff" rid="aff3-0022034512459655">3</xref>
<xref ref-type="corresp" rid="corresp1-0022034512459655">*</xref>
</contrib>
</contrib-group>
<aff id="aff1-0022034512459655"><label>1</label>Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, 1011 North University Ave., Office 3349, Ann Arbor, MI, 48109-1078, USA</aff>
<aff id="aff2-0022034512459655"><label>2</label>Department of Biomedical Engineering, College of Engineering, University of Michigan, Ann Arbor, MI, USA</aff>
<aff id="aff3-0022034512459655"><label>3</label>Michigan Center for Oral Health Research, School of Dentistry, University of Michigan, Ann Arbor, MI, USA</aff>
<author-notes>
<corresp id="corresp1-0022034512459655"><label>*</label><email>hrios@umich.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>11</month>
<year>2012</year>
</pub-date>
<volume>91</volume>
<issue>11</issue>
<fpage>1078</fpage>
<lpage>1084</lpage>
<history>
<date date-type="received">
<day>7</day>
<month>2</month>
<year>2012</year>
</date>
<date date-type="rev-recd">
<day>15</day>
<month>7</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>8</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© 2012 International &amp; American Associations for Dental Research</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">International &amp; American Associations for Dental Research</copyright-holder>
</permissions>
<abstract>
<p>Periostin, a matricellular adapter protein highly expressed by periodontal ligament fibroblasts, is implicated in the maintenance of periodontal integrity, which is compromised during periodontal diseases. The aim of this study was to explore the influence of chronic periodontal inflammation on tissue periostin levels. Periodontal breakdown was induced in a pre-clinical ligature periodontal inflammatory disease model. Periodontal tissue specimens were harvested at baseline, 2 weeks, and 4 weeks and prepared for histologic, immunofluorescence, and micro-CT examination. Statistical analyses were conducted by Kruskal-Wallis, Mann-Whitney, and Spearman’s tests. Periostin detection levels were reduced over time in response to the inflammatory process (1 ± 0.05; 0.67 ± 0.03; 0.31 ± 0.02; p &lt; 0.001; baseline, 2, and 4 weeks, respectively). Simultaneously, alveolar bone loss increased from baseline to the 2- and 4-week time-points (0.40 ± 0.02 mm; 1.39 ± 0.08 mm; 1.33 ± 0.15 mm; p &lt; 0.001), which was inversely correlated with the levels of periostin (ρ = -0.545; p &lt; 0.001). In conclusion, periostin PDL tissue levels significantly decrease under chronic inflammatory response and correlate with the detrimental changes to the periodontium over time.</p>
</abstract>
<kwd-group>
<kwd>periostin</kwd>
<kwd>periodontal ligament</kwd>
<kwd>periodontium</kwd>
<kwd>periodontal disease/periodontitis</kwd>
<kwd>bone resorption</kwd>
<kwd>extracellular matrix</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0022034512459655" sec-type="intro">
<title>Introduction</title>
<p>Loss of tooth-supporting structures affects up to 90% of the general worldwide adult population experiencing different types of periodontal diseases (<xref ref-type="bibr" rid="bibr15-0022034512459655">Papapanou, 1996</xref>) and constitutes the primary cause of tooth loss in adults aged 35 yrs and over (<xref ref-type="bibr" rid="bibr11-0022034512459655">Niessen and Weyant, 1989</xref>). Periodontal diseases are induced by bacteria acting in a susceptible host (<xref ref-type="bibr" rid="bibr14-0022034512459655">Page and Kornman, 1997</xref>). Different molecules act in this scenario, reflecting periodontal bone loss activity and susceptibility. However, because this is a highly complex disease, it is unlikely that a single biomarker for disease detection and prediction can be found (<xref ref-type="bibr" rid="bibr8-0022034512459655">Kinney <italic>et al</italic>., 2011</xref>).</p>
<p>During periodontal homeostasis and healing, cell turnover, recruitment, and differentiation are tightly regulated processes. In this context, matricellular molecules within the periodontal ligament (PDL) aim to stabilize the extracellular matrix (ECM) for supporting mechanical and biological challenges. They act by providing signals to the constituent cell populations to modulate their phenotype to maintain tissue homeostasis. In that sense, periostin (gene POSTN), a secreted adhesion molecule highly expressed in the PDL, is essential for periodontal tissue integrity. It also plays an important role in tooth development and eruption processes (<xref ref-type="bibr" rid="bibr9-0022034512459655">Kruzynska-Frejtag <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="bibr20-0022034512459655">Rios <italic>et al</italic>., 2005</xref>, <xref ref-type="bibr" rid="bibr21-0022034512459655">2008</xref>). Furthermore, periostin expression is increased in response to occlusal loading and orthodontic movement (<xref ref-type="bibr" rid="bibr26-0022034512459655">Wilde <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="bibr1-0022034512459655">Afanador <italic>et al</italic>., 2005</xref>). Its presence in the ECM is induced by biomechanical stimuli <italic>via</italic> TGF-ß1 signaling (<xref ref-type="bibr" rid="bibr21-0022034512459655">Rios <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="bibr25-0022034512459655">Wen <italic>et al</italic>., 2010</xref>). Once secreted, it modulates the matrix-cell interactions relevant to connective tissue repair and remodeling, fibroblast attachment and spreading (<xref ref-type="bibr" rid="bibr5-0022034512459655">Hamilton, 2008</xref>; <xref ref-type="bibr" rid="bibr6-0022034512459655">Hoersch and Andrade-Navarro, 2010</xref>), and activation of cell survival signaling pathways (<xref ref-type="bibr" rid="bibr2-0022034512459655">Bao <italic>et al</italic>., 2004</xref>). Periostin influences mechanical stability and tissue strength by regulating collagen fibrillogenesis (<xref ref-type="bibr" rid="bibr12-0022034512459655">Norris <italic>et al</italic>., 2007</xref>). Moreover, it has been recently used as a marker to investigate the functional integrity of a regenerated PDL interface (<xref ref-type="bibr" rid="bibr17-0022034512459655">Park <italic>et al</italic>., 2012</xref>). In contrast, reduction or absence of POSTN in KO mice leads to periodontal breakdown in a periodontal-disease-like process once occlusal loading starts after teeth eruption (<xref ref-type="bibr" rid="bibr20-0022034512459655">Rios <italic>et al</italic>., 2005</xref>, <xref ref-type="bibr" rid="bibr21-0022034512459655">2008</xref>). These properties highlight its key role during periodontal homeostasis, maintaining a healthy tooth-supporting apparatus against biomechanical challenges.</p>
<p>However, reductions in periostin levels as a co-factor for periodontal destruction and breakdown have not been yet studied <italic>in vivo</italic>. Therefore, the aim of this study was to explore the influence of spatial and temporal periodontal inflammation on the levels of the matricellular adapter protein periostin over time in an inflammatory-induced periodontal disease animal model. Accordingly, disease progression in terms of linear and volumetric bone changes, periostin levels, and inflammatory process was analyzed.</p>
</sec>
<sec id="section2-0022034512459655" sec-type="materials|methods">
<title>Materials &amp; Methods</title>
<sec id="section3-0022034512459655">
<title>Experimental Design</title>
<p>All animal procedures were approved by the University of Michigan Committee of Use and Care of Animals. Thirty male Sprague-Dawley rats (weight, 250-300 g each) were assigned to 3 equal experimental groups: control group at the time of ligature placement (baseline); animals subjected to disease induction for 2 wks; and animals subjected to disease induction for 4 wks.</p>
</sec>
<sec id="section4-0022034512459655">
<title>Ligature-induced Periodontal Disease</title>
<p>Sprague-Dawley rats were anesthetized <italic>via</italic> intraperitoneal injections of a ketamine and xylazine cocktail (<xref ref-type="bibr" rid="bibr19-0022034512459655">Rios and Giannobile, 2011</xref>). Silk sutures (4/0) were secured around the cervical parts of the right maxillary first and second molar teeth and placed in the gingival sulci. The ligatures were evaluated twice weekly, gently displaced apically into the gingival sulci to ensure a subgingival position, and replaced when dislodged or lost.</p>
</sec>
<sec id="section5-0022034512459655">
<title>Quantitative Micro-CT Analysis</title>
<p>Block biopsies were harvested at each time-point. Rat mandible specimens were fixed in a 10% buffered formalin phosphate solution for 1 day and scanned by micro-CT (eXplore Locus SP, GE Healthcare Inc., London, ON, Canada) with 18 × 18 × 18 µm<sup>3</sup> voxel size. Linear alveolar bone loss (ABL; mm) was determined in the interproximal area between the first and second molars by measurement of the distance from the cemento-enamel junction (CEJ) to the alveolar bone crest (ABC). After the teeth were digitally removed, regions of interest (ROI) for the assessment of mineralized tissue volume were created with the same size in the interproximal area between the first and second molars (<xref ref-type="bibr" rid="bibr16-0022034512459655">Park <italic>et al</italic>., 2007</xref>), extending from the apical end of the roots to the CEJ (<xref ref-type="fig" rid="fig1-0022034512459655">Fig. 1A</xref>). Based on the HU grayscale level, bone volume (BV; mm<sup>3</sup>), and bone mineral density [BMD; mg (HyAp)/cc] were quantified. MicroView Analysis+ 2.1.2 software (GE Healthcare) was used to perform these analyses. All measurements were repeated 2 times <italic>per</italic> site, and the mean value was recorded.</p>
<fig id="fig1-0022034512459655" position="float">
<label>Figure 1.</label>
<caption>
<p>µCT analyses. (<bold>A</bold>) Volumetric and linear µCT images depicting ROIs (yellow cubes), used for volumetric measurements, and CEJ (green arrows) and ABC (red arrows) anatomical landmarks, used for ABL measurements. Scale bar = 1 mm. (<bold>B</bold>) ABL (mm) was significantly lower at baseline than at 2 and 4 wks (a, p &lt; 0.001; Mann-Whitney). (<bold>C</bold>) BMD (mg/cc) was significantly lower at 2 (b, p &lt; 0.003; Mann-Whitney) and 4 wks (c, p &lt; 0.002; Mann-Whitney) after the ligature placement. Error bars represent SEM.</p>
</caption>
<graphic xlink:href="10.1177_0022034512459655-fig1.tif"/>
</fig>
</sec>
<sec id="section6-0022034512459655">
<title>Histologic and Immunofluorescence Analyses</title>
<p>After the µCT scanning, the harvested mandibles were decalcified with 10% ethylene diaminetetraacetic acid (EDTA; Sigma-Aldrich Co. LLC, St. Louis, MO, USA) for 4 wks and embedded in paraffin blocks for histological sectioning. Hematoxylin-eosin staining was used to evaluate bone destruction and soft-tissue changes.</p>
<p>Polymorphonuclear neutrophils (PMNs) and T-lymphocytes in the area were evaluated by immunohistochemical staining for myeloperoxidase and CD3, respectively. Briefly, after an antigen retrieval pre-treatment (citrate buffer, pH 6.0, boiled for 10 min), CD3 (1:200 dilution; ab5690, Abcam, Inc., Cambridge, MA, USA) and myeloperoxidase (1:250 dilution; ab45977, Abcam) primary antibodies were incubated for 30 min, followed by the addition of secondary antibodies (30 min), DAB staining (5 min), and hematoxylin counterstain (1 min) in an autostainer (EnVision+ protocol; Dako North America, Inc., Carpinteria, CA, USA). Sections were then dehydrated and covered with a glass coverslip. The ApopTag Kit (S7100; EMD Millipore Corporation, Billerica, MA, USA) was used to detect apoptotic cells. Three blinded examiners analyzed a total of 8 digital sections of each group and each staining (original magnification of 20X). Regions of interest measuring 200 x 300 µm were established in an apical direction from the most coronal contact between the soft tissue and the tooth surface, and positive cells were counted.</p>
<p>We also performed immunofluorescence staining to periostin on paraffin sections by using an affinity-purified rabbit polyclonal antibody (1:400 dilution; ab14041 Abcam). Immunological reaction was visualized by the use of a sheep polyclonal secondary antibody to rabbit conjugated with Texas Red™ (1:200 dilution; ab6793-1, Abcam). The sections were then treated with an anti-fade agent containing 4′,6-diamidino-2-phenylindole (DAPI) (ProLong<sup>®</sup> Gold anti-fade reagent with DAPI; Invitrogen, Life Technologies Corporation, Grand Island, NY, USA) and covered with a glass coverslip. The stained slides were imaged with an OLYMPUS Fluoview 500 confocal microscope (Olympus America Inc., Center Valley, PA, USA) at constant settings. ImageJ (National Institutes of Health, Bethesda, MD, USA; <ext-link ext-link-type="uri" xlink:href="http://rsbweb.nih.gov/ij/">http://rsbweb.nih.gov/ij/</ext-link>) was used to analyze the periostin fluorescence intensity. Briefly, areas to be analyzed extended from the ABC to the apex of the root, non-PDL areas were digitally subtracted, the entire figure was quantitatively mapped, and a mean fluorescent light intensity value was obtained and adjusted to total PDL area <italic>per</italic> image. All values were normalized to baseline. ImageJ was also used to represent the periostin intensity in a pseudo-3D figure (heat-map).</p>
</sec>
<sec id="section7-0022034512459655">
<title>Statistical Analysis</title>
<p>PASW Statistics 18.0 (SPSS Inc., Chicago, IL, USA) was used for the statistical analyses. All data are presented as the mean value ± SEM (standard error of the mean). The significance of the differences among groups was determined by the Kruskal-Wallis test (α = 0.05), since the population was not normally distributed (p &lt; 0.05, Shapiro-Wilk test). The Mann-Whitney U test was used to define pairwise statistical differences with Bonferroni correction (α = 0.0167). Spearman’s rank coefficient (α = 0.05) was used to demonstrate any correlations between variables.</p>
</sec>
</sec>
<sec id="section8-0022034512459655" sec-type="results">
<title>Results</title>
<sec id="section9-0022034512459655">
<title>Linear and Volumetric Analyses</title>
<p>ABL (mm) was significantly different among groups (p &lt; 0.001; Kruskal-Wallis). ABL in the baseline group (0.40 ± 0.02) was significantly lower than that in the diseased groups at both 2 (1.39 ± 0.08; p &lt; 0.001; Mann-Whitney) and 4 wks (1.33 ± 0.15; p &lt; 0.001; Mann-Whitney). No significant difference was found between the 2 diseased groups (p = 0.364) (<xref ref-type="fig" rid="fig1-0022034512459655">Figs. 1A</xref>, <xref ref-type="fig" rid="fig1-0022034512459655">1B</xref>).</p>
<p>Consistently, volumetric analysis (BV, mm<sup>3</sup>) revealed a significant difference among groups (p &lt; 0.001; Kruskal-Wallis). Baseline levels (0.77 ± 0.03) were significantly higher than those in disease at 2 (0.39 ± 0.04; p &lt; 0.001; Mann-Whitney) and 4 wks (0.37 ± 0.04; p &lt; 0.001; Mann-Whitney). No significant difference was found between the 2 diseased groups (p = 0.762; Mann-Whitney). BMD (mg/cc) was also significantly different among groups (p &lt; 0.002; Kruskal-Wallis), being significantly higher at baseline (198.61 ± 24.69) compared with that in disease at 2 (75.07 ± 21.31; p &lt; 0.003; Mann-Whitney) and 4 wks (97.58 ± 11.64; p &lt; 0.002; Mann-Whitney). No significant difference was found between the 2 diseased groups (p = 0.199; Mann-Whitney) (<xref ref-type="fig" rid="fig1-0022034512459655">Figs. 1A</xref>, <xref ref-type="fig" rid="fig1-0022034512459655">1C</xref>).</p>
</sec>
<sec id="section10-0022034512459655">
<title>Evaluation of the Inflammatory Process</title>
<p>Histological analysis demonstrated a high impact on PDL tissue structure over time (<xref ref-type="fig" rid="fig2-0022034512459655">Figs. 2A</xref>, <xref ref-type="fig" rid="fig3-0022034512459655">3A</xref>). In the baseline group, a well-organized PDL tissue was observed. ABC looked normal, without major Howship’s lacunae. PDL and gingival fibers showed a regular orientation from bone to tooth. In contrast, the 2-week group showed a disorganized PDL fiber orientation, and inflammatory infiltrated and reduced ABC, with those detrimental effects being even more evident for the 4-week group.</p>
<fig id="fig2-0022034512459655" position="float">
<label>Figure 2.</label>
<caption>
<p>Immunohistochemical analyses of the inflammatory process. (<bold>A</bold>) H&amp;E images showing inflammatory infiltrate and periodontal fiber disorganization over time. Original magnification: 40X. Scale bar: 50 µm. (<bold>B</bold>) Myeloperoxidase- and (<bold>C</bold>) CD3-immunopositive and (<bold>D</bold>) apoptotic cell detection (black arrows). Original magnification: 60X. Scale bar: 40 µm. (<bold>E</bold>) Myeloperoxidase- and (<bold>F</bold>) CD3-immunopositive and (<bold>G</bold>) apoptotic cell quantification showing a generalized increase of all markers compared with baseline (a, p &lt; 0.001, Mann-Whitney). Additionally, CD3-immunopositive and apoptotic cells significantly increased from 2 to 4 wks (b, p &lt; 0.011 and c, p &lt; 0.008, Mann-Whitney, respectively). Error bars represent SEM.</p>
</caption>
<graphic xlink:href="10.1177_0022034512459655-fig2.tif"/>
</fig>
<p>Specific immunohistochemical analyses showed a statistically significant increase of myeloperoxidase- (2.63 ± 0.65, 27.57 ± 4.69, 38.17 ± 9.74) (<xref ref-type="fig" rid="fig2-0022034512459655">Figs. 2B</xref>, <xref ref-type="fig" rid="fig2-0022034512459655">2E</xref>) and CD3-positive cells (4.5 ± 1.02, 19.71 ± 3.08, 33.86 ± 4.06) (<xref ref-type="fig" rid="fig2-0022034512459655">Figs. 2C</xref>, <xref ref-type="fig" rid="fig2-0022034512459655">2F</xref>) as well as apoptotic cells (2.0 ± 0.57, 30.86 ± 5.26, 64.5 ± 8.05) (<xref ref-type="fig" rid="fig2-0022034512459655">Figs. 2D</xref>, <xref ref-type="fig" rid="fig2-0022034512459655">2G</xref>) from baseline to 2 and 4 wks (p &lt; 0.001, Mann-Whitney). From 2 to 4 wks, CD3 and apoptotic positive cells increased significantly (p &lt; 0.011 and p &lt; 0.008, Mann-Whitney, respectively), but not myeloperoxidase (p = 0.534, Mann-Whitney).</p>
</sec>
<sec id="section11-0022034512459655">
<title>Periostin Levels</title>
<p>Periostin fluorescence intensity levels were significantly reduced over time by the effect of the inflammatory process induced by the ligature (p &lt; 0.001; Kruskal-Wallis) (<xref ref-type="fig" rid="fig3-0022034512459655">Figs. 3B</xref>, <xref ref-type="fig" rid="fig3-0022034512459655">3C</xref>). At baseline (1.0 ± 0.05), relative periostin levels were significantly higher than those in diseased groups at both 2 (0.67 ± 0.03; p &lt; 0.001; Mann-Whitney) and 4 wks (0.31 ± 0.02; p &lt; 0.001; Mann-Whitney). The difference between the 2- and 4-week groups was also statistically significant (p &lt; 0.001; Mann-Whitney) (<xref ref-type="fig" rid="fig3-0022034512459655">Fig. 3D</xref>).</p>
<fig id="fig3-0022034512459655" position="float">
<label>Figure 3.</label>
<caption>
<p>Histological and immunofluorescence analyses. (<bold>A</bold>) H&amp;E histological images showing alveolar bone reduction, inflammatory infiltrate, and periodontal fiber disorganization in the ligated interproximal region between the first and second molars over time. Original magnification: 20X. Scale bar: 100 µm. (<bold>B</bold>) Immunofluorescence images showing reduction of periostin immunolocalization (in red) over time. DAPI in blue. Original magnification: 20X. Scale bar: 100 µm. (<bold>C</bold>) Heat-map 3D representation of periostin immunofluorescence intensity from images presented in (B). (<bold>D</bold>) Significantly lower relative periostin levels in the PDL area at 2 and 4 wks compared with baseline (a, p &lt; 0.001; Mann-Whitney). Levels at 4 wks were also significantly lower than those at 2 wks (b, p &lt; 0.001; Mann-Whitney). Error bars represent SEM.</p>
</caption>
<graphic xlink:href="10.1177_0022034512459655-fig3.tif"/></fig>
</sec>
<sec id="section12-0022034512459655">
<title>Correlation between Levels of Periostin and Bone Destruction</title>
<p>Ligature-induced periodontal inflammation resulted in clear correlation of periostin levels and detrimental changes to the periodontium over time, at linear (ABL-periostin, r<sup>2</sup> linear = 0.681; ρ = −0.545, p &lt; 0.001, Spearman) (<xref ref-type="fig" rid="fig4-0022034512459655">Fig. 4A</xref>), volumetric (BV-periostin, r<sup>2</sup> linear = 0.762; ρ = 0.642, p &lt; 0.001, Spearman), and mineral density levels (BMD-periostin, r<sup>2</sup> linear = 0.565; ρ = 0.411, p &lt; 0.012, Spearman) (<xref ref-type="fig" rid="fig4-0022034512459655">Fig. 4B</xref>). Areas with lower levels of periostin corresponded to the areas where more coronal-apical detrimental tissue changes were noticeable (higher ABL, lower BV and BMD).</p>
<fig id="fig4-0022034512459655" position="float">
<label>Figure 4.</label>
<caption>
<p>Correlation between levels of periostin and bone destruction. <bold>(A</bold>) Correlation between mean levels of periostin and ABL (r<sup>2</sup> linear = 0.681; ρ = −0.545, p &lt; 0.001, Spearman). (<bold>B</bold>) Correlation between periostin levels and BMD (r<sup>2</sup> linear = 0.565; ρ = 0.411, p &lt; 0.012, Spearman). Error bars represent SEM for both the horizontal (periostin) and the vertical (ABL or BMD) axes. Orange dotted line: Confidence interval = 80%.</p>
</caption>
<graphic xlink:href="10.1177_0022034512459655-fig4.tif"/>
</fig>
</sec>
</sec>
<sec id="section13-0022034512459655" sec-type="discussion">
<title>Discussion</title>
<p>New insights into the pathogenesis of periodontitis incorporate gene, protein, and metabolite data into dynamic biological networks that include disease-initiating and progression mechanisms. Periostin as a modulator of critical matricellular interactions is relevant in those processes.</p>
<p>Of the known proteins expressed in the PDL, periostin shows the greatest specificity (<xref ref-type="bibr" rid="bibr22-0022034512459655">Saito <italic>et al</italic>., 2002</xref>). It is localized between the cytoplasmic processes of periodontal fibroblasts and cementoblasts and the adjacent collagen fibrils (<xref ref-type="bibr" rid="bibr23-0022034512459655">Suzuki <italic>et al</italic>., 2004</xref>). In those areas, periostin is closely related to the PDL fiber bundles from the root-surface cementum to the alveolar bone engaging the tooth-supporting apparatus and reflecting a mature and stable tissue (<xref ref-type="bibr" rid="bibr17-0022034512459655">Park <italic>et al</italic>., 2012</xref>).</p>
<p>In contrast, periostin deletion induces a reduction in collagen fiber diameter that results in a decreased tissue modulus of elasticity (<xref ref-type="bibr" rid="bibr12-0022034512459655">Norris <italic>et al</italic>., 2007</xref>). In the case of periostin KO mice, the periodontal ligament is unable to sustain the normal physiological occlusal load, which results in a rapid deterioration of the functional and structural integrity of the periodontium: advanced alveolar bone loss, severe clinical attachment loss, and significant widening of the PDL region (<xref ref-type="bibr" rid="bibr20-0022034512459655">Rios <italic>et al</italic>., 2005</xref>, <xref ref-type="bibr" rid="bibr21-0022034512459655">2008</xref>; <xref ref-type="bibr" rid="bibr10-0022034512459655">Ma <italic>et al</italic>., 2011</xref>). In the present study, the inflammatory process initiated by the ligature placement was able to induce a periostin reduction that was correlated with bone loss. This collateral effect of inflammation on periostin expression directly compromised the integrity of the PDL, favoring an inappropriate response to traumatic or even normal occlusal forces, ultimately leading to bone destruction and periodontal breakdown.</p>
<p>No significant differences in ABL, BV, or BMD were observed within the 2- and 4-week time-points, which is consistent with results of previous studies (<xref ref-type="bibr" rid="bibr7-0022034512459655">Jin <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="bibr18-0022034512459655">Pellegrini <italic>et al</italic>., 2009</xref>; <xref ref-type="bibr" rid="bibr19-0022034512459655">Rios and Giannobile, 2011</xref>). However, the levels of periostin were reduced from 2 to 4 wks. This observation may lead to subsequent bursts of periodontal destruction due to changes in the PDL tissue strength and ability to respond to mechanical challenges (<xref ref-type="bibr" rid="bibr12-0022034512459655">Norris <italic>et al</italic>., 2007</xref>). Periostin is primarily expressed within the PDL region by PDL fibroblasts (<xref ref-type="bibr" rid="bibr22-0022034512459655">Saito <italic>et al</italic>., 2002</xref>). Therefore, the decrease in periostin levels reflects the loss of PDL tissue integrity, which might be due to a switch from a well-organized PDL to an inflammatory infiltrated tissue. Analysis of our data shows a significant increase in T-lymphocytes (CD3-positive cells) and apoptotic cells at 4 wks <italic>vs</italic>. baseline and 2 wks. An initial significant increase in PMNs (myeloperoxidase-positive cells) was observed but not maintained from 2 to 4 wks. This scenario reflects an inflammation profile toward a more stable, yet chronic, inflammatory infiltrated tissue. Some studies have suggested an increase of periostin detection in other chronic pathological conditions, leading to a fibrotic situation (<xref ref-type="bibr" rid="bibr4-0022034512459655">Hakuno <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="bibr3-0022034512459655">Daines <italic>et al</italic>., 2011</xref>; <xref ref-type="bibr" rid="bibr24-0022034512459655">Uchida <italic>et al</italic>., 2012</xref>). Our results may indicate a different periostin expression pattern in periodontal diseases. When those differences are analyzed, the specific periodontal environment (bacterial contamination, mechanical requirements, etc.) must be considered. Based on our <italic>in vitro</italic> studies, the expression of periostin is specifically reduced in human PDL fibroblasts by the effects of inflammatory cytokines and bacterial by-products (<xref ref-type="bibr" rid="bibr13-0022034512459655">Padial-Molina <italic>et al</italic>.</xref>, Epub ahead of print). However, it is important to highlight that two overlapping scenarios could support the altered levels of periostin in the chronically inflamed periodontium: (1) Bacterial/inflammatory challenge could lead to decreased periostin produced by PDL fibroblasts, and (2) a decrease in the number of PDL fibroblasts could explain the lower periostin levels. Both scenarios represent an important observation with significant clinical implications that compromise the function and structure of the periodontium. When periostin is reduced or completely depleted, the stability of the PDL is compromised, and it is more susceptible to injury and the subsequent inflammatory process, since the structural and biomechanical capacities are reduced (<xref ref-type="bibr" rid="bibr20-0022034512459655">Rios <italic>et al</italic>., 2005</xref>, <xref ref-type="bibr" rid="bibr21-0022034512459655">2008</xref>). Therefore, the <italic>in vivo</italic> reduction of periostin in our periodontal inflammatory model occurs not only due to the changes in the PDL tissue (<italic>i.e</italic>., from an organized, specialized, and competent tissue to a chronic inflammatory infiltrated tissue, which contains less competent PDL fibroblasts capable of expressing periostin), but also due to a direct effect of the inflammatory molecular environment around the main periostin expressers (<italic>i.e</italic>., PDL fibroblasts). This inflammatory environment could further increase the pathological changes as tissue mechanical properties decrease. Such mechanisms support our present <italic>in vivo</italic> results and favor the idea of a complex regulatory pathway of periodontal tissue homeostasis where periostin is a key factor for maintaining tissue integrity under biomechanical, bacterial, and inflammatory challenges.</p>
<p>Periostin, a key factor for periodontal stability, is reduced as a consequence of inflammatory-induced periodontal disease. Periostin could represent a novel biological agent with significant potential for diagnostic and susceptibility assessment purposes. It could add supporting scientific information to capture the dynamic nature of the matricellular biochemical events involved in the transition between periodontal health and disease. Further studies of the diagnostic value of periostin as a marker for disease activity and susceptibility in humans, to confirm our <italic>in vitro</italic> and animal studies, are needed and have already been initiated by our group (clinicaltrials.gov Id #: NCT01180920).</p>
</sec>
</body>
<back>
<ack>
<p>The authors thank the Center for Statistical Consultation and Research (CSCAR) of the University of Michigan for assisting with the statistical analyses.</p>
</ack>
<fn-group>
<fn fn-type="supported-by">
<p>This study was supported by the <grant-sponsor>NIH/NIDCR</grant-sponsor><?release-delay 12|0?> (grants <grant-num>DE019872</grant-num> to HFR and <grant-num>DE13397</grant-num> to WVG), Amgen Inc. (N011869 to WVG), and the Talentia Scholarship Program (Junta de Andalucía, Spain to MPM).</p>
</fn>
<fn fn-type="conflict">
<p>The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Afanador</surname><given-names>E</given-names></name>
<name><surname>Yokozeki</surname><given-names>M</given-names></name>
<name><surname>Oba</surname><given-names>Y</given-names></name>
<name><surname>Kitase</surname><given-names>Y</given-names></name>
<name><surname>Takahashi</surname><given-names>T</given-names></name>
<name><surname>Kudo</surname><given-names>A</given-names></name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>Messenger RNA expression of periostin and Twist transiently decrease by occlusal hypofunction in mouse periodontal ligament</article-title>. <source>Arch Oral Biol</source> <volume>50</volume>:<fpage>1023</fpage>-<lpage>1031</lpage>.</citation>
</ref>
<ref id="bibr2-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bao</surname><given-names>S</given-names></name>
<name><surname>Ouyang</surname><given-names>G</given-names></name>
<name><surname>Bai</surname><given-names>X</given-names></name>
<name><surname>Huang</surname><given-names>Z</given-names></name>
<name><surname>Ma</surname><given-names>C</given-names></name>
<name><surname>Liu</surname><given-names>M</given-names></name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway</article-title>. <source>Cancer Cell</source> <volume>5</volume>:<fpage>329</fpage>-<lpage>339</lpage>.</citation>
</ref>
<ref id="bibr3-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Daines</surname><given-names>SM</given-names></name>
<name><surname>Wang</surname><given-names>Y</given-names></name>
<name><surname>Orlandi</surname><given-names>RR</given-names></name>
</person-group> (<year>2011</year>). <article-title>Periostin and osteopontin are overexpressed in chronically inflamed sinuses</article-title>. <source>Int Forum Allergy Rhinol</source> <volume>1</volume>:<fpage>101</fpage>-<lpage>105</lpage>.</citation>
</ref>
<ref id="bibr4-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hakuno</surname><given-names>D</given-names></name>
<name><surname>Kimura</surname><given-names>N</given-names></name>
<name><surname>Yoshioka</surname><given-names>M</given-names></name>
<name><surname>Mukai</surname><given-names>M</given-names></name>
<name><surname>Kimura</surname><given-names>T</given-names></name>
<name><surname>Okada</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents</article-title>. <source>J Clin Invest</source> <volume>120</volume>:<fpage>2292</fpage>-<lpage>2306</lpage>.</citation>
</ref>
<ref id="bibr5-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hamilton</surname><given-names>DW</given-names></name>
</person-group> (<year>2008</year>). <article-title>Functional role of periostin in development and wound repair: implications for connective tissue disease</article-title>. <source>J Cell Commun Signal</source> <volume>2</volume>:<fpage>9</fpage>-<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr6-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hoersch</surname><given-names>S</given-names></name>
<name><surname>Andrade-Navarro</surname><given-names>MA</given-names></name>
</person-group> (<year>2010</year>). <article-title>Periostin shows increased evolutionary plasticity in its alternatively spliced region</article-title>. <source>BMC Evol Biol</source> <volume>10</volume>:<fpage>30</fpage>.</citation>
</ref>
<ref id="bibr7-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jin</surname><given-names>Q</given-names></name>
<name><surname>Cirelli</surname><given-names>JA</given-names></name>
<name><surname>Park</surname><given-names>CH</given-names></name>
<name><surname>Sugai</surname><given-names>JV</given-names></name>
<name><surname>Taba</surname><given-names>M</given-names></name>
<name><surname>Kostenuik</surname><given-names>PJ</given-names></name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis</article-title>. <source>J Periodontol</source> <volume>78</volume>:<fpage>1300</fpage>-<lpage>1308</lpage>.</citation>
</ref>
<ref id="bibr8-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kinney</surname><given-names>JS</given-names></name>
<name><surname>Morelli</surname><given-names>T</given-names></name>
<name><surname>Braun</surname><given-names>T</given-names></name>
<name><surname>Ramseier</surname><given-names>CA</given-names></name>
<name><surname>Herr</surname><given-names>AE</given-names></name>
<name><surname>Sugai</surname><given-names>JV</given-names></name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Saliva/pathogen biomarker signatures and periodontal disease progression</article-title>. <source>J Dent Res</source> <volume>90</volume>:<fpage>752</fpage>-<lpage>758</lpage>.</citation>
</ref>
<ref id="bibr9-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kruzynska-Frejtag</surname><given-names>A</given-names></name>
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Maeda</surname><given-names>M</given-names></name>
<name><surname>Rogers</surname><given-names>R</given-names></name>
<name><surname>Krug</surname><given-names>E</given-names></name>
<name><surname>Hoffman</surname><given-names>S</given-names></name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>Periostin is expressed within the developing teeth at the sites of epithelial-mesenchymal interaction</article-title>. <source>Dev Dyn</source> <volume>229</volume>:<fpage>857</fpage>-<lpage>868</lpage>.</citation>
</ref>
<ref id="bibr10-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ma</surname><given-names>D</given-names></name>
<name><surname>Zhang</surname><given-names>R</given-names></name>
<name><surname>Sun</surname><given-names>Y</given-names></name>
<name><surname>Rios</surname><given-names>HF</given-names></name>
<name><surname>Haruyama</surname><given-names>N</given-names></name>
<name><surname>Han</surname><given-names>X</given-names></name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>A novel role of periostin in postnatal tooth formation and mineralization</article-title>. <source>J Biol Chem</source> <volume>286</volume>:<fpage>4302</fpage>-<lpage>4309</lpage>.</citation>
</ref>
<ref id="bibr11-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Niessen</surname><given-names>LC</given-names></name>
<name><surname>Weyant</surname><given-names>RJ</given-names></name>
</person-group> (<year>1989</year>). <article-title>Causes of tooth loss in a veteran population</article-title>. <source>J Public Health Dent</source> <volume>49</volume>:<fpage>19</fpage>-<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr12-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Norris</surname><given-names>RA</given-names></name>
<name><surname>Damon</surname><given-names>B</given-names></name>
<name><surname>Mironov</surname><given-names>V</given-names></name>
<name><surname>Kasyanov</surname><given-names>V</given-names></name>
<name><surname>Ramamurthi</surname><given-names>A</given-names></name>
<name><surname>Moreno-Rodriguez</surname><given-names>R</given-names></name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues</article-title>. <source>J Cell Biochem</source> <volume>101</volume>:<fpage>695</fpage>-<lpage>711</lpage>.</citation>
</ref>
<ref id="bibr13-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Padial-Molina</surname><given-names>M</given-names></name>
<name><surname>Volk</surname><given-names>SL</given-names></name>
<name><surname>Rodriguez</surname><given-names>JC</given-names></name>
<name><surname>Marchesan</surname><given-names>JT</given-names></name>
<name><surname>Galindo-Moreno</surname><given-names>P</given-names></name>
<name><surname>Rios</surname><given-names>HF</given-names></name>
</person-group> (<year>2012</year>). <article-title>TNF-alpha and <italic>P. gingivalis</italic> lipopolysaccharides decrease periostin expression in human PDL fibroblasts</article-title>. <source>J Periodontol</source> <comment>[Epub ahead of print July 6, 2012] (in press)</comment>.</citation>
</ref>
<ref id="bibr14-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Page</surname><given-names>RC</given-names></name>
<name><surname>Kornman</surname><given-names>KS</given-names></name>
</person-group> (<year>1997</year>). <article-title>The pathogenesis of human periodontitis: an introduction</article-title>. <source>Periodontol</source> <year>2000</year> <volume>14</volume>:<fpage>9</fpage>-<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr15-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Papapanou</surname><given-names>PN</given-names></name>
</person-group> (<year>1996</year>). <article-title>Periodontal diseases: epidemiology</article-title>. <source>Ann Periodontol</source> <volume>1</volume>:<fpage>1</fpage>-<lpage>36</lpage>.</citation>
</ref>
<ref id="bibr16-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Park</surname><given-names>CH</given-names></name>
<name><surname>Abramson</surname><given-names>ZR</given-names></name>
<name><surname>Taba</surname><given-names>Jr</given-names></name>
<name><surname>Jin</surname><given-names>Q</given-names></name>
<name><surname>Chang</surname><given-names>J</given-names></name>
<name><surname>Kreider</surname><given-names>JM</given-names></name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>Three-dimensional micro-computed tomographic imaging of alveolar bone in experimental bone loss or repair</article-title>. <source>J Periodontol</source> <volume>78</volume>:<fpage>273</fpage>-<lpage>281</lpage>.</citation>
</ref>
<ref id="bibr17-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Park</surname><given-names>CH</given-names></name>
<name><surname>Rios</surname><given-names>HF</given-names></name>
<name><surname>Jin</surname><given-names>Q</given-names></name>
<name><surname>Sugai</surname><given-names>JV</given-names></name>
<name><surname>Padial-Molina</surname><given-names>M</given-names></name>
<name><surname>Taut</surname><given-names>AD</given-names></name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Tissue engineering bone-ligament complexes using fiber-guiding scaffolds</article-title>. <source>Biomaterials</source> <volume>33</volume>:<fpage>137</fpage>-<lpage>145</lpage>.</citation>
</ref>
<ref id="bibr18-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pellegrini</surname><given-names>G</given-names></name>
<name><surname>Seol</surname><given-names>YJ</given-names></name>
<name><surname>Gruber</surname><given-names>R</given-names></name>
<name><surname>Giannobile</surname><given-names>WV</given-names></name>
</person-group> (<year>2009</year>). <article-title>Pre-clinical models for oral and periodontal reconstructive therapies</article-title>. <source>J Dent Res</source> <volume>88</volume>:<fpage>1065</fpage>-<lpage>1076</lpage>.</citation>
</ref>
<ref id="bibr19-0022034512459655">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Rios</surname><given-names>HF</given-names></name>
<name><surname>Giannobile</surname><given-names>WV</given-names></name>
</person-group> (<year>2011</year>). <article-title>Preclinical protocols for periodontal regeneration (Chapter 7)</article-title>. In: <source>Osteology guidelines for oral and maxillofacial regeneration: preclinical models for translational research</source>. <person-group person-group-type="editor">
<name><surname>Giannobile</surname><given-names>WV</given-names></name>
<name><surname>Nevins</surname><given-names>M</given-names></name>
</person-group>, editors. <publisher-loc>Berlin</publisher-loc>: <publisher-name>Quintessence Publishing Co., Inc.</publisher-name>, pp. <fpage>77</fpage>-<lpage>104</lpage>.</citation>
</ref>
<ref id="bibr20-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rios</surname><given-names>H</given-names></name>
<name><surname>Koushik</surname><given-names>SV</given-names></name>
<name><surname>Wang</surname><given-names>H</given-names></name>
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Zhou</surname><given-names>HM</given-names></name>
<name><surname>Lindsley</surname><given-names>A</given-names></name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>Periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype</article-title>. <source>Mol Cell Biol</source> <volume>25</volume>:<fpage>11131</fpage>-<lpage>11144</lpage>.</citation>
</ref>
<ref id="bibr21-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rios</surname><given-names>HF</given-names></name>
<name><surname>Ma</surname><given-names>D</given-names></name>
<name><surname>Xie</surname><given-names>Y</given-names></name>
<name><surname>Giannobile</surname><given-names>WV</given-names></name>
<name><surname>Bonewald</surname><given-names>LF</given-names></name>
<name><surname>Conway</surname><given-names>SJ</given-names></name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Periostin is essential for the integrity and function of the periodontal ligament during occlusal loading in mice</article-title>. <source>J Periodontol</source> <volume>79</volume>:<fpage>1480</fpage>-<lpage>1490</lpage>.</citation>
</ref>
<ref id="bibr22-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Saito</surname><given-names>Y</given-names></name>
<name><surname>Yoshizawa</surname><given-names>T</given-names></name>
<name><surname>Takizawa</surname><given-names>F</given-names></name>
<name><surname>Ikegame</surname><given-names>M</given-names></name>
<name><surname>Ishibashi</surname><given-names>O</given-names></name>
<name><surname>Okuda</surname><given-names>K</given-names></name>
<etal/>
</person-group>. (<year>2002</year>). <article-title>A cell line with characteristics of the periodontal ligament fibroblasts is negatively regulated for mineralization and Runx2/Cbfa1/Osf2 activity, part of which can be overcome by bone morphogenetic protein-2</article-title>. <source>J Cell Sci</source> <volume>115</volume>(<issue>Pt 21</issue>):<fpage>4191</fpage>-<lpage>4200</lpage>.</citation>
</ref>
<ref id="bibr23-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Suzuki</surname><given-names>H</given-names></name>
<name><surname>Amizuka</surname><given-names>N</given-names></name>
<name><surname>Kii</surname><given-names>I</given-names></name>
<name><surname>Kawano</surname><given-names>Y</given-names></name>
<name><surname>Nozawa-Inoue</surname><given-names>K</given-names></name>
<name><surname>Suzuki</surname><given-names>A</given-names></name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>Immunohistochemical localization of periostin in tooth and its surrounding tissues in mouse mandibles during development</article-title>. <source>Anat Rec A Discov Mol Cell Evol Biol</source> <volume>281</volume>:<fpage>1264</fpage>-<lpage>1275</lpage>.</citation>
</ref>
<ref id="bibr24-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Uchida</surname><given-names>M</given-names></name>
<name><surname>Shiraishi</surname><given-names>H</given-names></name>
<name><surname>Ohta</surname><given-names>S</given-names></name>
<name><surname>Arima</surname><given-names>K</given-names></name>
<name><surname>Taniguchi</surname><given-names>K</given-names></name>
<name><surname>Suzuki</surname><given-names>S</given-names></name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis</article-title>. <source>Am J Respir Cell Mol Biol</source> <volume>46</volume>:<fpage>677</fpage>-<lpage>686</lpage>.</citation>
</ref>
<ref id="bibr25-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wen</surname><given-names>W</given-names></name>
<name><surname>Chau</surname><given-names>E</given-names></name>
<name><surname>Jackson-Boeters</surname><given-names>L</given-names></name>
<name><surname>Elliott</surname><given-names>C</given-names></name>
<name><surname>Daley</surname><given-names>TD</given-names></name>
<name><surname>Hamilton</surname><given-names>DW</given-names></name>
</person-group> (<year>2010</year>). <article-title>TGF-ss1 and FAK regulate periostin expression in PDL fibroblasts</article-title>. <source>J Dent Res</source> <volume>89</volume>:<fpage>1439</fpage>-<lpage>1443</lpage>.</citation>
</ref>
<ref id="bibr26-0022034512459655">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wilde</surname><given-names>J</given-names></name>
<name><surname>Yokozeki</surname><given-names>M</given-names></name>
<name><surname>Terai</surname><given-names>K</given-names></name>
<name><surname>Kudo</surname><given-names>A</given-names></name>
<name><surname>Moriyama</surname><given-names>K</given-names></name>
</person-group> (<year>2003</year>). <article-title>The divergent expression of periostin mRNA in the periodontal ligament during experimental tooth movement</article-title>. <source>Cell Tissue Res</source> <volume>312</volume>:<fpage>345</fpage>-<lpage>351</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>